Y Ventures Group Ltd
SGX:1F1
Y Ventures Group Ltd
SGX:1F1
Price:
0.008
SGD
Market Closed
Market Cap:
S$3.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Y Ventures Group Ltd
SGX:1F1
|
SG |
|
OptiBiotix Health PLC
LSE:OPTI
|
UK |
|
Altarea SCA
OTC:ATRRF
|
FR |
|
A
|
Acarix AB
STO:ACARIX
|
SE |
|
Inversiones Doalca SOCIMI SA
MAD:YDOA
|
ES |
|
ANI Pharmaceuticals Inc
NASDAQ:ANIP
|
US |
|
Singapore Land Group Ltd
SGX:U06
|
SG |
|
Patterson-UTI Energy Inc
NASDAQ:PTEN
|
US |
|
N
|
New Tech Venture SA
WSE:NTV
|
PL |
|
Tokyu Corp
TSE:9005
|
JP |
|
Future Enterprises Ltd
NSE:FEL
|
IN |
|
MGP Ingredients Inc
NASDAQ:MGPI
|
US |
|
Samsung Life Insurance Co Ltd
KRX:032830
|
KR |
|
Bridgestone Corp
TSE:5108
|
JP |
Balance Sheet
Balance Sheet Decomposition
Y Ventures Group Ltd
Y Ventures Group Ltd
Balance Sheet Decomposition is not available for
Y Ventures Group Ltd
Y Ventures Group Ltd
Balance Sheet
Y Ventures Group Ltd
Y Ventures Group Ltd
Currency: USD
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & Cash Equivalents |
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
1
|
2
|
1
|
|
| Cash |
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
1
|
2
|
1
|
|
| Total Receivables |
1
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
1
|
|
| Accounts Receivables |
1
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
2
|
2
|
1
|
|
| Other Receivables |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
1
|
1
|
3
|
6
|
10
|
23
|
22
|
9
|
11
|
16
|
20
|
14
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
2
|
4
|
4
|
8
|
12
|
24
|
25
|
12
|
14
|
19
|
23
|
15
|
|
| PP&E Net |
2
|
2
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
2
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Total Assets |
4
N/A
|
5
+32%
|
6
+16%
|
10
+66%
|
13
+36%
|
26
+97%
|
26
+0%
|
14
-47%
|
14
+1%
|
19
+35%
|
23
+23%
|
16
-33%
|
|
| Liabilities | |||||||||||||
| Accounts Payable |
0
|
1
|
2
|
2
|
7
|
20
|
19
|
9
|
11
|
17
|
21
|
14
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
1
|
2
|
2
|
9
|
22
|
21
|
10
|
12
|
17
|
21
|
14
|
|
| Long-Term Debt |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
2
N/A
|
2
-17%
|
4
+82%
|
4
+2%
|
10
+174%
|
23
+131%
|
22
-6%
|
11
-51%
|
12
+14%
|
17
+44%
|
21
+23%
|
14
-33%
|
|
| Equity | |||||||||||||
| Common Stock |
0
|
0
|
0
|
8
|
9
|
10
|
11
|
11
|
11
|
11
|
12
|
12
|
|
| Retained Earnings |
1
|
3
|
2
|
2
|
5
|
7
|
6
|
8
|
9
|
10
|
10
|
11
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
2
N/A
|
3
+106%
|
2
-25%
|
6
+161%
|
3
-46%
|
3
-5%
|
5
+43%
|
3
-29%
|
2
-41%
|
2
-21%
|
2
+25%
|
1
-29%
|
|
| Total Liabilities & Equity |
4
N/A
|
5
+32%
|
6
+16%
|
10
+66%
|
13
+36%
|
26
+97%
|
26
+0%
|
14
-47%
|
14
+1%
|
19
+35%
|
23
+23%
|
16
-33%
|
|
| Shares Outstanding | |||||||||||||
| Common Shares Outstanding |
168
|
168
|
168
|
200
|
205
|
230
|
242
|
247
|
400
|
400
|
494
|
494
|
|
Switch to:
Switch to:
See Also
Discover More
